🚀 VC round data is live in beta, check it out!
CapsoVision Valuation Multiples
Discover revenue and EBITDA valuation multiples for CapsoVision and similar public comparables like Semler Scientific, Shoulder Innovations, NIOX Group, Abbott Pakistan and more.
CapsoVision Overview
About CapsoVision
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company’s core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company’s products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
Founded
2005
HQ
Employees
90
Website
Sectors
Financials (LTM)
EV
$302M
CapsoVision Financials
CapsoVision reported last 12-month revenue of $14M and negative EBITDA of ($25M).
In the same LTM period, CapsoVision generated $8M in gross profit, ($25M) in EBITDA losses, and had net loss of ($25M).
Revenue (LTM)
CapsoVision P&L
In the most recent fiscal year, CapsoVision reported revenue of $14M and EBITDA of ($25M).
CapsoVision expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $14M | XXX | $14M | XXX | XXX | XXX |
| Gross Profit | $8M | XXX | $7M | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 53% | XXX | XXX | XXX |
| EBITDA | ($25M) | XXX | ($25M) | XXX | XXX | XXX |
| EBITDA Margin | (176%) | XXX | (184%) | XXX | XXX | XXX |
| EBIT Margin | (177%) | XXX | (188%) | XXX | XXX | XXX |
| Net Profit | ($25M) | XXX | ($25M) | XXX | XXX | XXX |
| Net Margin | (176%) | XXX | (187%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
CapsoVision Stock Performance
CapsoVision has current market cap of $311M, and enterprise value of $302M.
Market Cap Evolution
CapsoVision's stock price is $6.25.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $302M | $311M | -2.2% | XXX | XXX | XXX | $-0.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCapsoVision Valuation Multiples
CapsoVision trades at 21.3x EV/Revenue multiple, and (12.1x) EV/EBITDA.
EV / Revenue (LTM)
CapsoVision Financial Valuation Multiples
As of April 11, 2026, CapsoVision has market cap of $311M and EV of $302M.
Equity research analysts estimate CapsoVision's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CapsoVision has a P/E ratio of (12.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $311M | XXX | $311M | XXX | XXX | XXX |
| EV (current) | $302M | XXX | $302M | XXX | XXX | XXX |
| EV/Revenue | 21.3x | XXX | 22.3x | XXX | XXX | XXX |
| EV/EBITDA | (12.1x) | XXX | (12.1x) | XXX | XXX | XXX |
| EV/EBIT | (12.1x) | XXX | (11.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 39.1x | XXX | 42.1x | XXX | XXX | XXX |
| P/E | (12.5x) | XXX | (12.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (13.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CapsoVision Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
CapsoVision Margins & Growth Rates
CapsoVision's revenue in the last 12 month grew by 32%.
CapsoVision's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
CapsoVision's rule of 40 is (137%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CapsoVision's rule of X is (112%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
CapsoVision Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 32% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | (176%) | XXX | (184%) | XXX | XXX | XXX |
| EBITDA Growth | (10%) | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (137%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (112%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 55% | XXX | 56% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 49% | XXX | 51% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 127% | XXX | 135% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 241% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
CapsoVision Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Semler Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Shoulder Innovations | XXX | XXX | XXX | XXX | XXX | XXX |
| NIOX Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Abbott Pakistan | XXX | XXX | XXX | XXX | XXX | XXX |
| RxSight | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CapsoVision M&A Activity
CapsoVision acquired XXX companies to date.
Last acquisition by CapsoVision was on XXXXXXXX, XXXXX. CapsoVision acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by CapsoVision
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCapsoVision Investment Activity
CapsoVision invested in XXX companies to date.
CapsoVision made its latest investment on XXXXXXXX, XXXXX. CapsoVision invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by CapsoVision
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CapsoVision
| When was CapsoVision founded? | CapsoVision was founded in 2005. |
| Where is CapsoVision headquartered? | CapsoVision is headquartered in United States. |
| How many employees does CapsoVision have? | As of today, CapsoVision has over 90 employees. |
| Who is the CEO of CapsoVision? | CapsoVision's CEO is Kang-Huai Johnny Wang. |
| Is CapsoVision publicly listed? | Yes, CapsoVision is a public company listed on Nasdaq. |
| What is the stock symbol of CapsoVision? | CapsoVision trades under CV ticker. |
| When did CapsoVision go public? | CapsoVision went public in 2025. |
| Who are competitors of CapsoVision? | CapsoVision main competitors are Semler Scientific, Shoulder Innovations, NIOX Group, Abbott Pakistan. |
| What is the current market cap of CapsoVision? | CapsoVision's current market cap is $311M. |
| What is the current revenue of CapsoVision? | CapsoVision's last 12 months revenue is $14M. |
| What is the current revenue growth of CapsoVision? | CapsoVision revenue growth (NTM/LTM) is 32%. |
| What is the current EV/Revenue multiple of CapsoVision? | Current revenue multiple of CapsoVision is 21.3x. |
| Is CapsoVision profitable? | No, CapsoVision is not profitable. |
| What is the current EBITDA of CapsoVision? | CapsoVision has negative EBITDA and is not profitable. |
| What is CapsoVision's EBITDA margin? | CapsoVision's last 12 months EBITDA margin is (176%). |
| What is the current EV/EBITDA multiple of CapsoVision? | Current EBITDA multiple of CapsoVision is (12.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.